The government owes Pfizer almost $5 billion for COVID-19 treatment pills it already ordered. Two senior officials told Bloomberg that the Biden administration plans to pay Pfizer for the 20 million courses of the antiviral pill using funds generated by the new pandemic relief bill. Another senior official said that it’s unclear where the money to pay Pfizer would come from, and the White House declined to comment.
The bill is currently stalling over disagreements regarding pandemic immigration laws. It was initially slated to be worth $22.5 billion, but after negotiations between parties, the fund was reduced to $10 billion, half of which is required to be spent on therapeutics.
“The bill is a start,” Jeff Zients, White House COVID-19 response coordinator said at a press briefing March 5. “Congress must keep working to immediately provide additional funding for our remaining domestic needs.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
